McLeod综合征与其他神经棘红细胞增多症综合征的分子基础与临床概览:一篇综述
本文综述McLeod综合征的临床表现与分子基础,该病由XK基因变异引起,与亨廷顿病有相似之处但表现多样。文章汇总了国际输血协会整理的XK等位基因列表,强调精确的系统性遗传分类有助于理解表型多样性并指导临床治疗。
要点
- McLeod综合征由XK基因变异所致,为X连锁遗传,男性患者主要表现为McLeod血型表型。
- 该病通常在约40岁起出现神经和心脏症状,需神经科与输血医学等多学科参与诊断。
- 精确的系统性遗传分类是理解该病表型多样性的第一步,可能指导临床治疗。
核心结论
- McLeod综合征由XK基因等位变异或涉及XK及邻近基因的连续基因缺失综合征所致,临床表现为多样的神经、神经肌肉和心脏症状。
- 更精确的系统性遗传分类是关联和理解McLeod综合征多样表型表现的第一步,可能指导临床治疗及对患者和携带者家庭成员的支持。
研究设计与样本
- 本文为综述,讨论McLeod综合征的临床表现和分子基础,并提供迄今已发表的与该综合征相关的等位基因综合列表。
主要发现
- McLeod综合征通常在个体约40岁起出现神经和心脏症状,并具有独特的血液学表现及特定输血需求。
- 国际输血协会(International Society of Blood Transfusion)最近整理并 curated 了与McLeod表型相关的XK等位基因列表。
- 由结构变异引起的McLeod综合征以及作为连续基因缺失综合征一部分诊断的病例,先前被归类于单一等位基因命名之下。
临床怎么用
- 本综述为神经科医生、血液科医生和临床遗传学家提供了关于这一罕见且致衰性疾病的知识基础。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: McLeod syndrome, encoded by the gene XK, is a rare and progressive disease that shares important similarities with Huntington disease but has widely varied neurologic, neuromuscular, and cardiologic manifestations. Patients with McLeod syndrome have a distinct hematologic presentation with specific transfusion requirements. Because of its X-linked location, loss of the XK gene or pathogenic variants in this gene are principally associated with the McLeod blood group phenotype in male patients. The clinical manifestation of McLeod syndrome results from allelic variants of the XK gene or as part of a contiguous gene deletion syndrome involving XK and adjacent genes, including those for chronic granulomatous disease, Duchenne muscular dystrophy, and retinitis pigmentosa. McLeod syndrome typically manifests as neurologic and cardiologic symptoms that evolve in individuals beginning at approximately 40 years of age. OBSERVATIONS: Diagnosis of McLeod syndrome encompasses a number of specialties, including neurology and transfusion medicine. However, information regarding the molecular basis of the syndrome is incomplete, and clinical information is difficult to find. The International Society of Blood Transfusion has recently compiled and curated a listing of XK alleles associated with the McLeod phenotype. Of note, McLeod syndrome caused by structural variants as well as those cases diagnosed as part of a contiguous gene deletion syndrome were previously classified under a singular allele designation. CONCLUSIONS AND RELEVANCE: This review discusses the clinical manifestations and molecular basis of McLeod syndrome and provides a comprehensive listing of alleles with involvement in the syndrome published to date. This review highlights the clinical diversity of McLeod syndrome and discusses the development of molecular tools to elucidate genetic causes of disease. A more precise and systematic genetic classification is the first step toward correlating and understanding the diverse phenotypic manifestations of McLeod syndrome and may guide clinical treatment of patients and support for affected and carrier family members. This review provides a knowledge base for neurologists, hematologists, and clinical geneticists on this rare and debilitating disease.
引用
- Roulis E, Hyland C, Flower R, et al. Molecular Basis and Clinical Overview of McLeod Syndrome Compared With Other Neuroacanthocytosis Syndromes: A Review. JAMA Neurol. 2018. PMID: 30128557. doi:10.1001/jamaneurol.2018.2166
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。